NFKB1 and neoplasm: Suppressive agents inhibit tumor promotion through several mechanisms which include the inhibition of apoptosis, cell cycle arrest, the inhibition of angiogenesis and pathways sustaining cancer cells such as nuclear factor kappa B (NFκB), and the induction of cell differentiation [45,49].